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Abstract
Additional surgical interventions apart from emergencies during cesarean section are 
not recommended in the textbooks; thus, surgical procedures like myomectomy as an 
adjunct to cesarean section remains a hot topic of discussion. There are many publica-
tions supporting serosal myomectomy during cesarean section, but studies published so 
far are poor in quality of evidence. To clarify the efficacy and safety of cesarean myomec-
tomy, large-scale randomized controlled studies and studies explaining the mid-term 
and long-term outcomes of the cesarean myomectomy are required. Traditionally, cesar-
ean myomectomy is performed from the uterine serosa as in the usual abdominal myo-
mectomy. Although the surgical technique is the same as intracapsular myomectomy, a 
novel cesarean myomectomy technique, endometrial myomectomy, introduced into the 
obstetrics practice for minimizing the risk of adhesion formation and diminishing the 
blood loss during surgery. Further, strong studies are needed to overcome the contro-
versy on cesarean myomectomy.
Keywords: endometrial myomectomy, cesarean section, serosal myomectomy, 
complications
1. Introduction
Among the benign uterine diseases, leiomyoma of the uterus seems to be the most common 
pathology. Though the endometrium is accepted as a dynamic tissue and myometrium is 
accepted as a silent muscular tissue, the reality is not that and it was understood from the 
studies that both endometrial processes and myometrial processes play a role in abnormal 
uterine bleeding.
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
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Uterine leiomyomas, also known as fibroids, are smooth muscle-derived benign masses rang-
ing from millimeters to many centimeters. The investigation of pathological specimens of the 
uterus revealed that almost 80% of African Americans women and 70% of Caucasian women 
have detectable leiomyomas [1, 2]. The well-known risk factors for leiomyoma do not explain 
why racial difference is this much but genetic polymorphisms including increased aromatase 
activity and signal transducing genes showed that more severe phenotypic pattern may be 
seen in African Americans [3, 4].
Inadequacy of medical treatment and lack of understanding of molecular physiology and 
pathophysiological processes make the surgical treatment as the main therapeutic option for 
leiomyomas [5].
Leiomyomas of the uterus are highly vascular benign tumors, and their volume may increase 
9% in 6-month period. Growth rate of the myomas decreases after the age of 35 among 
Caucasian women and almost all myomas carried to menopausal period without any symp-
toms shrink in size together with the shrinkage of the uterus [6].
There are only limited options for the treatment of leiomyomas of the uterus, and most of 
the time leiomyomas are asymptomatic and no treatment is necessary. For asymptomatic 
patients, menopause itself is a cure factor [7].
There are numerous medical treatment options for the treatment of leiomyoma of the uterus 
like OCPs, progestins, NSAIDs, androgenic compounds, antifibrinolytics and progestin-
loaded IUDs for symptom relief, and they are likely effective in at least a group of patients [8].
Other treatment options related to the use of GnRH agonists, GnRH antagonists and estrogen 
and progestin add back regimens may decrease the volume of the leiomyomas but after the 
cessation of medical treatment, leiomyomas resume their volume within 6 months of time 
[9–11].
Surgical therapy remains the definitive treatment option in symptomatic leiomyomas. 
Hysterectomy for the patients with no fertility problem increases the quality of the life of leio-
myoma patients. Hysterectomy can be done by open surgery, laparoscopy or robotic-assisted 
surgery. Supracervical or subtotal hysterectomy is a controversial issue [12–14]. Abdominal 
myomectomy is the first surgical option for those who refuse to lose their uterus and who 
want to preserve their fertility for childbearing. Myomectomy can be done by open surgery, 
laparoscopic surgery and robotic-assisted surgery [15, 16]. For those who have submucous 
myomas, hysteroscopic resection is the gold standard treatment choice.
2. Cesarean myomectomy
One of the most controversial issues of obstetrics and gynecology is the presence of known or 
incidental leiomyomas during pregnancy and how to manage patients with myomas together 
with pregnancy. A total of 10–30% of the pregnancies develop some complications related to 
leiomyomas [17].
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Cesarean section is the most commonly performed procedure globally [18]. Due to more 
advanced age, pregnancies are more prevalent in developed countries, naturally encounter-
ing leiomyoma during cesarean section getting more prevalent as well. The prevalence of the 
leiomyomas during pregnancy varies from 0.37–12% in the current literature [19–21].
Performing myomectomy during cesarean section is a controversial topic. The main concern 
is the potential risk of severe bleeding and increased morbidity when it is performed during 
cesarean section [22]. However, accumulating number of publications to support cesarean 
myomectomy in recent years is merging.
Potential indications of cesarean myomectomy are listed in Table 1.
Contraindications of cesarean myomectomy are listed in Table 2.
In contrary to common belief, Tinelli et al. presented that serosal myomectomy has a minus-
cule impact on blood loss in the light of no difference in blood product transfusion rates when 
it performed during cesarean section [23]. Ramesh et al. investigated 21 cases of cesarean 
myomectomy retrospectively and concluded that myomectomy during cesarean section is not 
associated with intraoperative and postoperative complications [24]. Leiomyomas located at 
the cornual region were not removed in their study. Mangala et al. compared the blood loss 
in single fibroid in abdominal and cesarean myomectomy cases and concluded that there is 
no significant difference between the groups, and it is safe to remove the single leiomyoma 
during cesarean section [25]. Machado et al. studied eight cases in Oman for the safety of 
cesarean myomectomy and concluded that in selected patients, cesarean myomectomy is 
safe and efficient in the hands of experienced surgeons and in the tertiary healthcare facilities 
[26]. Kwon et al. investigated 165 pregnant women having myomas, and they evaluated the 
patients whose myomas are over 5 cm in size and concluded that the size of the myoma has 
no greater impact on the increased rates of complications [27]. Sparic et al. assessed 350 papers 
on cesarean myomectomy and 38 studies found to be eligible for their evaluation for review of 
cesarean myomectomy in modern obstetrics. The major risk is intraoperative bleeding ranging 
Symptomatic myomas (mild pelvic pain)
Myoma >5 cm
Single myoma
Anteriorly located myomas
Tumor previa
Pedunculated myomas
Avoiding extra surgical procedure
Degenerative myomas
Patient’s desire
Table 1. Potential indications of cesarean myomectomy.
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from 0 to 35.3%. A potential late complication is the scar quality after the surgery. This may 
increase the risk of  uterine rupture during the next pregnancy, but the literature lacks studies 
related to scar quality. However, Sparic et al. noted the advantages of cesarean myomectomy 
as smaller incision on the serosal surface, easy to perform during cesarean section, effortless 
suture placement and two operations in one. Another important advantage of cesarean myo-
mectomy is the improved quality of life in affected women. However, they concluded that the 
risk benefit of cesarean myomectomy should be re-evaluated and further research is neces-
sary [28]. Song et al. reviewed myomectomy during cesarean section through the database 
search and among 2500 studies they found nine studies eligible for their review and concluded 
that cesarean myomectomy may be a reasonable option in some leiomyoma patients but data 
driven from the meta-analysis were low quality, and definitive conclusion on this issue cannot 
be drawn [29].
Synchronous uterine contractions are mandatory for a healthy delivery. The uterus has no 
triggering mechanism as pacemaker in the heart, instead, uterine muscles have self- oscil-
lators triggered by the changing membrane potentials happening in the pregnancy period 
and their contractility increases toward the end of the gestation [31]. Myocyte contractility 
also increased by the facilitation of prostaglandins and myocyte to myocyte connectivity 
and activated intracellular contractile mechanism, which eventually increase the intrauterine 
pressure that effaces and dilates the cervix for the babies to be delivered. Any leiomyoma or 
other uterine pathologies may have negative effect on the uterine contractility and also any 
surgical procedure related to the uterine musculature might have negative impact on the 
uterine contractility and may increase the risk of uterine rupture during delivery. Decreasing 
the myocyte damage during myomectomy should be taken into consideration during any 
myomectomy cases.
Uterine pathologies including the leiomyoma have negative impact on the implantation and 
placentation [32]. Submucosal and intramural myomas deforming the endometrial surface 
reduce the implantation rates and increase the risk of abortion and mallocated placentation. 
The intramural leiomyoma not affecting the endometrial cavity is still a question. Number, size 
and locations of the myomas determine their impact. Small leiomyoma without endometrial 
Age > 40 years
Multiple myomas
Cornual located myomas
Posteriorly located myomas
Asymptomatic myomas
Tendency to bleed
Previous history of uterine rupture
Table 2. Contraindications of cesarean myomectomy.
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impact has no adverse effects [33]. Leiomyoma classified according to new myoma classifica-
tion from type 0 (submucous myoma) to type 8 (Parasitic myomas) [34]. In this study, the 
leiomyomas were in the range of type 2 and type 5.
The human uterus may increase in volume and weight, 1000 times and 20 times respectively 
throughout pregnancy [35, 36]. However, myomas can only grow one in fourth size dur-
ing pregnancy. Thus, myomectomy during cesarean section produces less tissue damage 
compared to removal of a symptomatic myoma in normal sized uterus. Serosal scarring and 
myocyte damage during myomectomy in nonpregnant uterus is more than that of cesarean 
myomectomy especially endometrial myomectomy. After all cumulated publications about 
the safety of cesarean myomectomies, severe bleeding and possibility of cesarean hysterec-
tomy still remain controversial issue though these two complications are no common. Conforti 
et al. described techniques for reducing hemorrhagic blood loss in their study published in 
European Journal of Obstetrics & Gynecology and Reproductive Biology including tourniquet, uter-
ine artery ligation, uterine artery embolization, vasopressin, tranexamic acid and uterotonic 
agents like oxytocin, misoprostol and dinoprostone, GnRH analogs before the operation, 
recycling of lost blood during surgery and gelatin matrix [31]. Desai et al. described a novel 
technique for reducing the blood loss during myomectomy, and they used selective uterine 
devascularization in nine pregnant patients before myomectomy at the time of cesarean sec-
tion. The ovarian vessels were ligated on both sides, and the ascending and the descend-
ing uterine artery branches were ligated bilaterally after the removal of baby and placental 
materials. All cases were managed successfully after the selective devascularization, and they 
found this technique as a safe and effective method [32]. Uterine artery ligation is lifesaving 
procedure during cesarean myomectomy of big-sized myomas as in the case reported by Ma 
et al. in Taiwanese Journal of Obstetrics and Gynecology [33]. Blood loss due to myomectomy fol-
lowing cesarean section is calculated by the weighing the swabs used during the surgery and 
volumetric measurement of aspirated blood and recorded. Loss of blood in cesarean section 
was not recorded but before beginning myomectomy, the uterus and lower uterine segment 
incision site were stabilized for any major or minor bleeding. In a meta-analysis conducted 
by Song et al., they searched many databases without language restriction and included only 
nine studies eligible for investigation and they concluded that though cesarean myomectomy 
can be a reasonable option, cesarean myomectomy remains still controversial because the 
data are not satisfactory [29].
Literature search for cesarean myomectomies revealed many publications supporting the 
cesarean myomectomy. In the retrospective study conducted by Topcu et al., 76 cesarean myo-
mectomy cases were compared with 60 cesarean only cases for blood loss, operation time, the 
need for transfusion and hospital stay and concluded that size of the myoma is not important 
and removal of corporal and subserous myomas is safe and feasible in some patients [36]. In a 
large group of cases in a university hospital setting, Li et al. investigated the efficacy of cesar-
ean myomectomy of 1242 cases by comparing three groups of cases where 200 cases without 
myoma (group A), 145 cases with myoma but without myomectomy (group B) and 51 cases 
with myoma during pregnancy resulted in cesarean hysterectomy (group C), and they con-
cluded that myomectomy during cesarean section is a safe and effective surgical method [37]. 
Sparic et al. analyzed the decision 289 making in cesarean myomectomy and concluded that 
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surgical skills, age of the patient and type of the myomas are the most important predictors 
of cesarean myomectomy [38].
Cesarean myomectomy has been consistently applied in our setting for 17 years. Beginning 
from 2013, endometrial myomectomy has been started and selected as the cesarean myo-
mectomy of choice instead of classical serosal approach because in serosal myomectomy, the 
bleeding, operative time, myometrial damage and adhesion formation possibilities are higher 
as compared to endometrial myomectomy [30]. The rate of suturing the endometrium during 
surgery is very low and uterine involution itself shrinks the surgical site to a lesser size. The 
surgery raises the question whether the endometrial myomectomy increases the likelihood 
of intrauterine adhesions or Asherman syndrome. We performed ultrasound evaluation at 
seventh day postoperation and evaluated the myometrial defect and found totally normal 
appearance in 22 cases. Also we called all patients 40 days after the surgery for saline infusion 
sonohysterography (SIS) and SIS outcomes revealed that no single case experienced intrauter-
ine adhesions at any level. SIS has been neglected for long time in infertility, but actually SIS is 
a simple and important investigation for intrauterine pathologies. Intrauterine adhesions can 
be verified by simple SIS as an adjunct to other diagnostic tools [39]. CS myomectomy from 
endometrial approach decreases loss of blood, total operation time and adhesion formation 
compared to classical cesarean myomectomy.
Hospital stay is no longer than classical myomectomies. Uterine serosa remains intact.
Endometrial myomectomy uses the principles of hysteroscopic myomectomy and supported 
by the physiological mechanism of uterine involution to decrease the blood loss and suturing 
during surgery. In this surgical method, unintentional opening of uterine serosa is accepted 
as complication because the main goal of this surgery is to remove all myomas from the endo-
metrial layer without touching the serosal layer for preserving the uterus from dense adhe-
sions and ease the future surgeries of the patient. All myomas located in anterior or posterior 
region and even the ones located close to cornual area can be safely removed by this surgical 
technique.
In the following section, we describe the techniques of serosal myomectomy and endometrial 
myomectomy in detail.
2.1. Techniques of cesaraen myomectomy
There are two approaches for removing the leiomyomas during cesarean section; one is the 
well-known serosal myomectomy and second is the novel technique recently published 
endometrial myomectomy. Both techniques use the same principle of intracapsular myoma 
removal, but the only difference is the route of myoma removal. Removing myomas by endo-
metrial route have some advantages over the serosal myomectomy and both techniques are 
explained in the following section in detail.
2.2. Technique of serosal myomectomy
Serosal myomectomy is the removal of the leiomyomas as in abdominal or laparoscopic 
myomectomy where incisions were made on the surface of the uterus. The only difference 
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is the enlarged and well-vascularized uterus during cesarean section. Uterine involu-
tion squeezes the big vessels in the endometrial cavity, but the surface blood supply is 
not affected from the involution thus the risk of bleeding during serosal myomectomy 
is increased. Besides, the incision on the surface remains large which may have greater 
impact on the adhesion formation. In cases where multiple myoma removal is necessary, 
the number of incisions increases and the risk of bleeding and formation of adhesions 
increases. In serosal myomectomy, removal of posterior myomas and myomas close to 
the cornual region are not recommended. Myomas close to each other may be removed 
from the same incision to diminish the adhesion formation.
Following removal of baby and the placenta, the uterine cavity is swept by a gauze and incision 
site is controlled for any bleeding and lower uterine segment incision is closed with a running 
nonlocked no. 1 Vicryl suture. Uterine surface is evaluated for the locations and the sizes of the 
myomas present. Leiomyoma close to the low uterine segment incision site was taken out as 
described in endometrial myomectomy technique. Closed proximity of the leiomyomas was 
removed from a single incision to diminish the adhesion formation. Leiomyoma located in dif-
ferent locations is removed by incising each leiomyoma surface thus sutures and scarring on 
the surface of the uterus are prominent in classical technique. While removing the myoma, if 
myoma base carries a vascular pedicle, then the pedicle is clamped and sutured. The muscular 
layer is closed by separate no. 1 Vicryl sutures. The serosal surface is closed in either continuous 
locked no. 1 Vicryl sutures or a baseball suturing technique. After suturing a very hot sponge is 
placed on the suture line for a short time and then removed to see any bleeding foci. Any resis-
tant bleeding not controlled by electrocautery may be controlled by no. 2 Vicryl U sutures or by 
figure of eight sutures around the suture line. No antiadhesion material is used for protection. 
After removal and suturing of all myomas, uterus is placed in the abdominal cavity and the 
serosal surface of the uterus and the tubes and ovaries are checked for bleeding and following 
hemostasis and clot removal the abdominal layers are closed according to the general principles.
The long-term effect of this method is the adhesion formation, which makes the latter abdomi-
nal surgeries prone to complications. Hemostatic sutures for bleeding result in many suture 
nodes on the uterine surface and may prolong time of surgery.
In 2013, Cengiz Tokgöz M.D. developed a new cesarean myomectomy technique which was 
named as endometrial myomectomy. The main aim of this novel technique is to minimalize 
the uterine scarring and eventual adhesion formation while using the uterine physiology as 
the main support for this surgical procedure. Until 2017, more than 30 cases were operated by 
this technique and 22 of the cases without posterior myomas were drilled into a retrospective 
study for publishing the preliminary outcomes of this novel technique. The technique was 
published in the Journal of Maternal Fetal and Neonatal Medicine as the first in the world and this 
study is the first and unique to compare one cesarean myomectomy technique(endometrial 
myomectomy) with another one (serosal myomectomy).
2.3. Technique of endometrial myomectomy
All myomectomy cases were performed by the same team of surgeons and cesarean section 
technique and myomectomy techniques used in these surgeries were the same. After removal 
Pros and Cons of Myomectomy during Cesarean Section
http://dx.doi.org/10.5772/intechopen.75365
71
of the baby and the placenta, the uterus is taken out from the abdominal cavity. The uterine 
cavity is swept by a gauze and uterine incision is controlled for any bleeding. Uterine surface 
and cavity are evaluated thoroughly for leiomyomas and anatomical locations and sizes are 
evaluated quickly. Those leiomyomas located close to the low uterine incision site (Picture 1) 
are removed from the incision line, which is neither a serosal nor an endometrial myomec-
tomy, and in fact, the myoma (Picture 3) is removed from subendometrial-intramyometrial 
area (Picture 2). The death space is closed together with the low uterine incision line suturing 
thus no extra suturing is necessary in such conditions.
Courtesy of Oğuz Güler M.D. & Cengiz Tokgöz M.D.
Following palpation and localization, leiomyomas (Picture 4) were pushed from the serosal 
site to be visible and palpable from endometrial site, then an endometrial-transmyometrial 
incision was made (Picture 5) to reach the leiomyoma by a scalpel or electrocautery knife 
and leiomyoma(Picture 6) was removed without its capsule (Picture 7) by blunt and sharp 
dissections.
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Courtesy of Şafak Hatırnaz M.D. & Oğuz Güler M.D.
Any vascular structures at the root of leiomyoma were clamped and sutured (Picture 8). 
If more than one leiomyoma are present and not close to each other, then all leiomyomas 
removed from one by one and endometrium is incised for each leiomyoma. However, the 
endometrium has the opportunity to involute rapidly and the endometria incisions diminish 
in size, which makes the endometrial scar smaller than the original incision. If the myoma 
removal site is not bleeding and the diameter of the incision on the endometrial layer <3 cm, 
no sutures are placed on the endometrial layer to minimalize the adhesion formation within 
the endometrial cavity. This is what is done in hysteroscopic submucous or intramural 
myoma resection where suturing is impossible to do. If suturing is necessary for bigger inci-
sions or bleeding, the no. 1 rapid Vicryl separate or continuous sutures are placed on the 
endometrial incision sites. By this technique, almost all myomas located on the uterus can be 
easily removed from the endometrium including subserous non pedunculated leiomyomas. 
Subserous myoma removal from the endometrium may seem to be unnecessary, but serosa 
of the uterus remains intact and the myometrial tissue damage diminishes while uterus is 
involuted. Thus, the death space in the myometrial layer is not observed, and myometrial 
integrity is not affected too much following this surgical procedure. Uterine physiology is the 
major supporter in this technique.
Following bleeding control, any bleeding sites were sutured if present and if no major 
bleeding, myoma bed or death spaces are sutured with no. 1 Vicryl in a separated manner. 
Endometrium is sutured with an absorbable suture in cases where the defect site is bigger than 
3 cm. Any serosal opening during subendometrial myomectomy is accepted as complication 
because the main goal of this surgical method is to keep the uterine serosa intact apart from 
cesarean lower uterine segment incision scar and by this way to minimize the adhesion for-
mation which is a matter of fact in myomectomies. In cases where reaching myoma is difficult, 
the team preferred to use bivalves to open the endometrial cavity for a safe surgical proce-
dure. Uterus itself is the major supporter of this surgery since the rapid physiological invo-
lution of the uterus diminishes the death spaces and suture sites thus endometrial scarring 
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Figure 1. Saline infusion sonohysterography (SIS) 40 days after endometrial myomectomy. Courtesy of Oğuz Güler M.D.
minimizes automatically. After inspection and hemostasis, lower uterine segment incision is 
closed and layers of the abdomen are closed carefully.
Postoperative care was not different from the cesarean section cases, and no additional treat-
ment or follow-up was recommended for endometrial myomectomy cases.
Number of the leiomyomas, leiomyoma sizes, amount of blood lost during this procedure, 
serosal opening during surgery and operation time are all recorded. Leiomyomas are sent for 
pathological evaluation in all cases.
All patients are called 5 days after the hospital discharge for postoperative control and the 
uterus, the endometrium and the surgical sites of leiomyoma removal are evaluated carefully by 
Intraoperative bleeding
Postoperative fever
Blood transfusion
Prolonged hospital stay
Adhesion formation
Asherman syndrome
Abnormal placental insertions
Uterine rupture
Table 3. Early and late complications of cesarean myomectomy.
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transabdominal ultrasound and recorded. Every single patient is called for saline infusion sonog-
raphy (SIS) 40 days after the surgery (when the uterine involution is ended and the uterus reaches 
the normal size) for the evaluation of endometrial damage or adhesion formation routinely and 
SİS findings are also recorded. Asherman syndrome at any level was not recorded in studied cases.
Among the studied 22 cases, four of them were operated for next cesarean section, and no 
leiomyoma formation or adhesion formation was observed during their next surgeries.
Both techniques carry some risks and complications during and after surgery. The complica-
tions related to cesarean myomectomy are listed in Table 3.
A picture of SIS 40 days after the operation is depicted in Figure 1.
3. Conclusions
Cesarean myomectomy still remains a controversial issue in obstetrics practice and seems to 
continue to be debated in the future. Because none of the studies were performed as randomized 
controlled trials so far, and meta-analyses derived from those studies have weak outcomes to 
say that cesarean myomectomy is a safe and reliable procedure. The accumulating data, how-
ever, diminished the fear of performing cesarean myomectomy.
Though this novel method of cesarean myomectomy, endometrial myomectomy, decreases 
the adhesion formation by keeping the uterine serosa intact, diminishes blood loss and reduce 
the operation time compared to serosal myomectomy, large-scale randomized controlled tri-
als need to show mid-term and long-term outcomes of this novel approach. Much safer and 
technically easier methods may change the steady thoughts on the risks of cesarean myomec-
tomy in future.
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